Literature DB >> 17636341

A case of homozygous familial hypercholesterolemia with focal segmental glomerulosclerosis.

Ahmet Midhat Elmaci1, Harun Peru, Fatih Akin, Zuhal Akcoren, Melda Caglar, Ahmet Ozel.   

Abstract

Familial hypercholesterolemia (FH) is a common autosomal dominant inherited disorder characterized by increased levels of circulating plasma low-density lipoprotein cholesterol (LDL-C), tendon xanthomas, and premature atherosclerotic cardiovascular disease. Homozygous FH occurs in only one in a million people. Focal segmental glomerulosclerosis (FSGS) is clinically characterized by proteinuria, which is marked in the majority of cases and accompanied by nephrotic syndrome, high incidence of hypertension, and progression to renal failure. To our knowledge, we herein report for the first time a case of homozygous FH associated with FSGS. A seven-and-a-half-year-old boy was referred to our hospital due to cutaneous xanthomata and growth retardation. He had multiple nodular yellowish cutaneous xanthomatous lesions each 1 cm in size over his knees and sacral region. Laboratory data included cholesterol level of 1,050 mg/dl, low density lipoprotein cholesterol (LDL-C) 951 mg/dl, high-density lipoprotein cholesterol (HDL-C) 29 mg/dl, triglycerides 168 mg/dl, total protein 6.3 g/dl, and albumin 3.2 g/dl. Urinary protein excretion was 78 mg/m(2) per hour. A percutaneous renal biopsy was performed, and histological findings showed FSGS. Treatment with cholestyramine and atorvastatin was unsuccessful in terms of lowering lipids, and he was placed on weekly sessions of plasmapheresis. Total cholesterol was reduced from 1,050 mg/dl to 223 mg/dl, LDL-C from 951 mg/dl to 171 mg/dl, and urinary protein excretion from 78 mg/m(2) per hour to 42 mg/m(2) per hour after eight sessions of plasmapheresis. It is our belief that plasmapheresis is a treatment of choice in patients with FSGS associated with FH.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17636341     DOI: 10.1007/s00467-007-0534-y

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  10 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Hypercholesterolemia and glomerular diseases in urinary screening of school children.

Authors:  T Asami; H Hayakawa; K Ohkawa; M Uchiyama
Journal:  Pediatr Nephrol       Date:  1999-02       Impact factor: 3.714

Review 3.  Regulation of the mevalonate pathway.

Authors:  J L Goldstein; M S Brown
Journal:  Nature       Date:  1990-02-01       Impact factor: 49.962

4.  Portacaval shunt and hyperlipidemia.

Authors:  T E Starzl; C W Putnam; L J Koep
Journal:  Arch Surg       Date:  1978-01

Review 5.  Lipids and the kidney.

Authors:  W F Keane
Journal:  Kidney Int       Date:  1994-09       Impact factor: 10.612

6.  Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia.

Authors:  D W Bilheimer; J L Goldstein; S M Grundy; M S Brown
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

7.  Difference in the risk factors for coronary, renal and other peripheral arteriosclerosis in heterozygous familial hypercholesterolemia.

Authors:  Kunimasa Yagi; Senshu Hifumi; Atushi Nohara; Toshinori Higashikata; Akihiro Inazu; Kiyo-O Mizuno; Masanobu Namura; Kosei Ueda; Junji Kobayashi; Masami Shimizu; Hiroshi Mabuchi
Journal:  Circ J       Date:  2004-07       Impact factor: 2.993

8.  Portacaval shunt and liver transplantation in treatment of familial hypercholesterolemia.

Authors:  D W Bilheimer
Journal:  Arteriosclerosis       Date:  1989 Jan-Feb

9.  LDL-apheresis; potential procedure for prevention and regression of atheromatous vascular lesion.

Authors:  S Yokoyama; A Yamamoto; R Hayashi; M Satani
Journal:  Jpn Circ J       Date:  1987-09

Review 10.  Glomerular structures and lipids in progressive renal disease.

Authors:  J F Moorhead; D C Wheeler; Z Varghese
Journal:  Am J Med       Date:  1989-11       Impact factor: 4.965

  10 in total
  3 in total

Review 1.  Lipid biology of the podocyte--new perspectives offer new opportunities.

Authors:  Alessia Fornoni; Sandra Merscher; Jeffrey B Kopp
Journal:  Nat Rev Nephrol       Date:  2014-05-27       Impact factor: 28.314

2.  Autosomal Recessive Hypercholesterolemia Caused by a Novel LDLRAP1 Variant and Membranous Nephropathy in a Chinese Girl: A Case Report.

Authors:  Siqin Feng; Xinyue Zhao; Yifei Wang; Yiyang Wang; Gang Chen; Shuyang Zhang
Journal:  Front Cardiovasc Med       Date:  2022-02-04

Review 3.  The Vicious Cycle of Renal Lipotoxicity and Mitochondrial Dysfunction.

Authors:  Mengyuan Ge; Flavia Fontanesi; Sandra Merscher; Alessia Fornoni
Journal:  Front Physiol       Date:  2020-07-07       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.